transmission = ? antibiotic transmission?

It seems that cannot be "the transmission of the antibiotic in the infection spot".

Context:


Unfortunately, it is doubtful that these efforts will have the resources, leverage, and influence on policy makers to have a meaningful eff ect on antibiotic use and resistance. How high-level recommendations can have a global effect on antibiotic prescribing and transmission control in the real world of physicians’ offices, hospital wards, and long-term care facilities is not clear. Nor is it clear how these efforts can change public attitudes about antibiotic use. Those leading these international e? orts urgently need to develop an understanding and recognition of the most successful approaches, wherever they are working, so that these strategies can be repeated and spread. It will be very useful to examine how the attitudes, culture, and practices of one community can be transferred to another, and how stewardship programmes in one 21 country can be implemented in diverse settings.


More context:

Essentially, even as we are forced to revisit treatments that are more than 30 years old while waiting desperately for new research to bear fruit, we sense a pervasive belief in the scientific community that increasing resistance is the new norm. This is a misleading and costly attitude, both in human and economic terms.Some action has been taken in response to the mounting crisis. For example, the Infectious DiseasesSociety of America, 17 US Centers for Disease Control andPrevention (CDC), 18 European commission, 19 EuropeanCentre for Disease Prevention and Control (ECDC) 20, and other expert groups and non-governmental organisations have worked hard to raise awareness and provoke action by government and industry.

National awareness campaigns to educate the public and health-care workers about appropriate outpatient antibiotic use have been undertaken in many countries 21. The effect of these campaigns in curbing antibiotic use is difficult to assess, but seems positive 21. The ECDC holds a European Antibiotic Awareness Day (EAAD) on Nov 18 each year. 22

In 2010, Canada joined the EAAD, and the CDC Get Smart programme was highlighted during the same week in November as the EAAD. Under the Swedish presidency of the European Union, a cooperative venture was set up between the USA and Europe in 2009 (the Transatlantic Task Force for Antibiotic Resistance). WHO has also voiced its serious concern by designating antimicrobial resistance as the focus of World Health Day on April 7, 2011.

Unfortunately, it is doubtful that these efforts will have the resources, leverage, and influence on policy makers to have a meaningful eff ect on antibiotic use and resistance. How high-level recommendations can have a global effect on antibiotic prescribing and transmission control in the real world of physicians’ offices, hospital wards, and long-term care facilities is not clear. Nor is it clear how these efforts can change public attitudes about antibiotic use. Those leading these international e? orts urgently need to develop an understanding and recognition of the most successful approaches, wherever they are working, so that these strategies can be repeated and spread. It will be very useful to examine how the attitudes, culture, and practices of one community can be transferred to another, and how stewardship programmes in one 21 country can be implemented in diverse settings.